Wu A J, Kurrasch R H, Katz J, Fox P C, Baum B J, Atkinson J C
Clinical Investigations and Patient Care Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
J Cell Physiol. 1994 Nov;161(2):217-26. doi: 10.1002/jcp.1041610205.
Interferon-gamma (IFN-gamma) is a product of activated T-lymphocytes, and tumor necrosis factor-alpha (TNF-alpha) is a product of both lymphocytes and macrophages. These cell types are often present at sites of tissue damage secondary to chronic infection or autoimmune disease. The purpose of this study was to characterize the effects of TNF-alpha and IFN-gamma on a human submandibular gland epithelial cell line (HSG). IFN-gamma caused a concentration-dependent decrease in HSG cell growth (approximately 70% in 6 days). Conversely, TNF-alpha alone had little effect on the growth of these cells. When these cytokines were added in combination (20 units/ml TNF-alpha and 1,000 units/ml of IFN-gamma), there was a synergistic antiproliferative effect; no apparent cell growth was observed. The cytokine-induced antiproliferative effect was reversible. After the apparent cessation of cell growth for 3-6 days, removal of the cytokines permitted complete growth recovery. Further, cells that recovered and exhibited growth patterns that were similar to control cells remained susceptible to the antiproliferative effects of the cytokines. Flow cytometry revealed that the percentage of cells in G0/G1 with the combination of cytokines was significantly increased by 24 h. The antiproliferative effect of IFN-gamma alone and that of IFN-gamma and TNF-alpha in combination were blocked completely using an antibody to the IFN-gamma receptor. A hypothesized mechanism of tissue damage in autoimmune inflammatory disorders is via up-regulation of cell surface markers such as intercellular adhesion molecule type I (ICAM-1) and histocompatibility antigen HLA-DR which can exacerbate the inflammatory process. Treatment of HSG cells with IFN-gamma, with or without TNF-alpha, resulted in increased levels of ICAM-1 and the acquisition of HLA-DR expression. These aggregate data suggest that IFN-gamma alone can regulate the expression of cell surface markers involved in the inflammatory process as well as cause a potent yet reversible inhibition of HSG cell growth that is modulated by the presence of TNF-alpha.
干扰素-γ(IFN-γ)是活化T淋巴细胞的产物,肿瘤坏死因子-α(TNF-α)是淋巴细胞和巨噬细胞的产物。这些细胞类型常出现在慢性感染或自身免疫性疾病继发的组织损伤部位。本研究的目的是描述TNF-α和IFN-γ对人下颌下腺上皮细胞系(HSG)的影响。IFN-γ导致HSG细胞生长呈浓度依赖性下降(6天内约下降70%)。相反,单独的TNF-α对这些细胞的生长几乎没有影响。当将这些细胞因子联合添加(20单位/毫升TNF-α和1000单位/毫升IFN-γ)时,存在协同抗增殖作用;未观察到明显的细胞生长。细胞因子诱导的抗增殖作用是可逆的。在细胞生长明显停止3至6天后,去除细胞因子可使生长完全恢复。此外,恢复并表现出与对照细胞相似生长模式的细胞仍然对细胞因子的抗增殖作用敏感。流式细胞术显示,联合使用细胞因子时,G0/G1期细胞的百分比在24小时时显著增加。使用抗IFN-γ受体抗体可完全阻断单独IFN-γ以及IFN-γ与TNF-α联合的抗增殖作用。自身免疫性炎症疾病中组织损伤的一种假设机制是通过上调细胞表面标志物,如细胞间黏附分子I型(ICAM-1)和组织相容性抗原HLA-DR,这会加剧炎症过程。用IFN-γ处理HSG细胞,无论有无TNF-α,都会导致ICAM-1水平升高并获得HLA-DR表达。这些综合数据表明,单独的IFN-γ可调节参与炎症过程的细胞表面标志物的表达,并对HSG细胞生长产生有效但可逆的抑制作用,这种抑制作用受TNF-α的存在调节。